Latest Diabetes: Type II news
ENDO: More Than Half of Adults With T2DM Who Discontinue GLP-1 Receptor Agonists Reinitiate Treatment
posted June 17th
by modernClinician Editorial Team
by modernClinician Editorial Team
ADA: Orforglipron Beneficial for Reducing HbA1c in Type 2 Diabetes
posted June 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
ENDO: GLP-1 Receptor Agonists Tied to Higher Hypotension Risk in Patients on BP Meds
posted June 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Rapid-Acting Inhaled Insulin for Children
posted June 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 Related Articles
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Type 2 Diabetes Linked to Worse Menopausal Symptoms 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD .jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk Monthly Specialist Briefings
Stay Connected
